Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.
Synopsys (SNPS) has drawn fresh attention after NASA selected the company, alongside EMA, to help verify Artemis spacesuit performance in the lunar environment using digital twin and electromagnetic simulation tools.
See our latest analysis for Synopsys.
At a share price of US$449.58, Synopsys has seen a 14.62% 7 day share price return and a 6.96% 30 day share price return, although its 90 day share price return of a 12.92% decline contrasts with a 1 year total shareholder return of 8.77%. This suggests recent momentum is rebuilding after a weaker spell.
If space technology and AI tools like Synopsys interest you, it can be worth widening the lens with other names benefiting from similar themes using our 38 AI infrastructure stocks
With annual revenue of US$8.01b, net income of US$1.11b, and a small 2.73% intrinsic discount indicated, plus an 18.67% gap to analyst targets, you have to ask if Synopsys is still mispriced or if the market already reflects its future growth.
At US$449.58, the most followed narrative puts Synopsys’ fair value at US$537.75, implying a meaningful gap that hinges on long term earnings power.
The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, dramatically expanding its addressable market into sectors like automotive, industrial, and aerospace. This is expected to support long-term top-line growth as more sophisticated and complex products (especially AI-powered and smart devices) require robust simulation, analysis, and EDA tools.
Curious what underpins that valuation gap? The narrative focuses on assumptions of sustained double digit revenue expansion, rising margins, and a rich earnings multiple that reflects Synopsys’ premium status.
Result: Fair Value of $537.75 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, that upside story can unravel if China related export pressures persist, or if the Ansys integration and IP business transition weigh more heavily on margins and growth than expected.
Find out about the key risks to this Synopsys narrative.
While the first narrative leans on discounted cash flow to argue Synopsys is 2.7% below fair value, the current P/E of 77.9x stands far above the 43.9x fair ratio, the 29.7x US Software average, and the 40.4x peer average. That kind of premium can either signal quality or raise valuation risk, so which side do you lean toward?
See what the numbers say about this price — find out in our valuation breakdown.
NasdaqGS:SNPS P/E Ratio as at Apr 2026
Mixed messages in the numbers and narratives so far? Check the data for yourself, weigh the trade offs, then see the 2 key rewards and 3 important warning signs
If Synopsys has you thinking more broadly about where to put fresh capital to work, now is the time to scan the market for other opportunities rather than wait on the sidelines.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SNPS.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com